{"database": "openregs", "table": "documents", "rows": [["FDA-2008-D-0610-0020", "FDA", "FDA-2008-D-0610", "Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic - Guidance for Industry", "Other", "Guidance", "2020-05-08T04:00:00Z", 2020, 5, "2020-05-08T04:00:00Z", null, "2024-12-18T13:51:32Z", null, 1, 0, "0900006484591e76"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2008-D-0610-0020"], "units": {}, "query_ms": 73.21393489837646, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}